申请人:Pfizer Limited
公开号:EP0166533A1
公开(公告)日:1986-01-02
A quinolone inotropic agent of the formula
or a pharmaceutically acceptable salt thereof, wherein «Het» is an optionally substituted 5-membered monocyclic aromatic heterocyclic group containing at least one nitrogen atom in the aromatic ring and attached by a nitrogen atom of said ring to the 5-, 6-, 7-or 8-position of said quinolone;
R, which is attached to the 5-, 6-, 7- or 8-position, is hydrogen, C1-C4 alkyl, C1-C4 alkoxy, hydroxy, CF3, halo, cyano or hydroxymethyl;
and the dashed line between the 3- and 4-positions represents an optional bond.
一种喹诺酮正性肌力药物,其化学式为或其药学上可接受的盐,其中“Het”是一种可选取代的5-成员单环芳杂环基团,其在芳香环上至少含有一个氮原子,并由该环的氮原子连接到所述喹诺酮的5-、6-、7-或8-位置;连接到5-、6-、7-或8-位置的R为氢、C1-C4烷基、C1-C4烷氧基、羟基、CF3、卤素、氰基或羟甲基;虚线连接3-和4-位置表示可选键。